Valvular & structural heart disease
Outcomes of Combined Left Atrial Appendage Occlusion and Transcatheter Mitral Edge-to-Edge Repair: The WATCH-TEER Study
Authors' conclusion
Combining LAAO with MTEER is feasible in patients who have a clinical indication for both procedures.
Study context
- Population
- Patients with an approved clinical indication for both mitral transcatheter edge-to-edge repair (MTEER) with MitraClip and left atrial appendage occlusion (LAAO) with WATCHMAN-FLXincluded between October 2020 and March 2024
- Participants
- 24 patients
- Outcome
- Composite of:
- All-cause mortality
- Stroke
- Life-threatening
- Major bleeding
- Follow-up
- 45 days
Main finding
As reported in the abstract
Combined LAAO and MTEER
21%
5/24 of 24
- All events occurred after discharge: cardiac death
- 1
- Ischemic stroke
- 1
- Trauma-related intracranial hemorrhage
- 1
- Nonprocedural major bleeds
- 2
Observational data: associations, not effects.
Further findings
Baseline characteristics
- Mean age
- 79.5 ± 6.3 years
- Males
- 83%
- Society of Thoracic Surgeons operative risk score
- 11.8% ± 5.3%
- CHA2DS2-VASc score
- 4.5 ± 1.1
- HAS-BLED score
- 3.3 ± 1.5
Total procedure time
- Total procedure time
- 103.6 ± 33.7 minutes
Mitral regurgitation and NYHA functional class · 45 days
- ≤2+ mitral regurgitation
- 68%
- NYHA functional class I-II symptoms
- 72%
Not on anticoagulation · 45 days
- Not on anticoagulation at 45 days
- 71%
- Not on anticoagulation at baseline
- 20%
Original publication
Outcomes of Combined Left Atrial Appendage Occlusion and Transcatheter Mitral Edge-to-Edge Repair: The WATCH-TEER Study. JACC Adv. Published 8 January 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →